Emma Persson
Company: Argenx
Job title: Clinical Scientist
Seminars:
Phase 2 Clinical Study into Empasiprubart for Multifocal Motor Neuropathy 11:30 am
Targeting C2 to inhibit function and downstream complement activation Reducing tissue inflammation and adaptive immune responses in autoimmune indications Clinical update on Empasiprubart for MMNRead more
day: Conference Day Two
Panel Discussion: Navigating the Complexities of Complement Inhibition in CNS Disorders 12:00 pm
Understanding the interplay between complement activation and neuroinflammation Differentiating between beneficial and detrimental complement pathways in CNS disease Balancing risks and benefits of complement inhibition in the CNSRead more
day: Conference Day Two